prednisolone has been researched along with Chronic Hepatitis C in 36 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One hundred and fifty-six consecutive patients with chronic hepatitis C were randomly assigned to be treated blind with tapering doses of oral prednisolone or placebo for 4 weeks." | 9.09 | Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C. ( Ampurdanès, S; Coll, S; Costa, J; Enríquez, J; Forns, X; Guilera, M; Morillas, R; Planas, R; Rodés, J; Sáiz, JC; Sánchez-Tapias, JM; Solà, R; Soler, M; Torras, X, 2000) |
| "Pegylated interferon combined with ribavirin treatment is an effective therapy for chronic hepatitis C viral infection." | 7.80 | Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)-CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report. ( Hidaka, H; Jiang, W; Kitagawa, H; Koizumi, W; Nakazawa, T, 2014) |
| " The complex immunological response to interferon and ribavirin may induce or exacerbate the autoimmune condition; however, VKH disease is a very rare complication associated with interferon therapy in chronic hepatitis C." | 7.77 | Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C. ( Jang, JY; Jeong, SW; Kim, HS; Kim, SG; Kim, YS; Lee, SH; Lee, YN; Lim, JH; Park, TK, 2011) |
| "A 70-year-old Japanese woman with hepatitis C virus (HCV) infection was diagnosed with polymyositis and treated with high-dose prednisolone (PSL)." | 7.73 | Marked increase of serum hepatitis C virus (HCV) RNA titer during treatment with high-dose prednisolone in a case of polymyositis. ( Fukuda, J; Kato, T; Okai, T; Shiroma, T; Tadokoro, M; Yokohari, R, 2005) |
| "Pioglitazone was effective in decreasing serum HCV RNA at day-14 (n = 10; difference of means = 205,618 IU/ml; 95% CI 26,600 to 384,600; P<0." | 6.77 | Pioglitazone decreases hepatitis C viral load in overweight, treatment naïve, genotype 4 infected-patients: a pilot study. ( Buck, M; Chojkier, M; Donohue, M; Elkhayat, H; Sabry, D, 2012) |
| "One hundred and fifty-six consecutive patients with chronic hepatitis C were randomly assigned to be treated blind with tapering doses of oral prednisolone or placebo for 4 weeks." | 5.09 | Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C. ( Ampurdanès, S; Coll, S; Costa, J; Enríquez, J; Forns, X; Guilera, M; Morillas, R; Planas, R; Rodés, J; Sáiz, JC; Sánchez-Tapias, JM; Solà, R; Soler, M; Torras, X, 2000) |
| "Pegylated interferon combined with ribavirin treatment is an effective therapy for chronic hepatitis C viral infection." | 3.80 | Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)-CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report. ( Hidaka, H; Jiang, W; Kitagawa, H; Koizumi, W; Nakazawa, T, 2014) |
| " The complex immunological response to interferon and ribavirin may induce or exacerbate the autoimmune condition; however, VKH disease is a very rare complication associated with interferon therapy in chronic hepatitis C." | 3.77 | Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C. ( Jang, JY; Jeong, SW; Kim, HS; Kim, SG; Kim, YS; Lee, SH; Lee, YN; Lim, JH; Park, TK, 2011) |
| "A 70-year-old Japanese woman with hepatitis C virus (HCV) infection was diagnosed with polymyositis and treated with high-dose prednisolone (PSL)." | 3.73 | Marked increase of serum hepatitis C virus (HCV) RNA titer during treatment with high-dose prednisolone in a case of polymyositis. ( Fukuda, J; Kato, T; Okai, T; Shiroma, T; Tadokoro, M; Yokohari, R, 2005) |
| "Factors associated with HCV recurrence were evaluated." | 2.79 | Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes. ( Burroughs, AK; Cholongitas, E; Corbani, A; Davidson, B; Davidson, J; Dhillon, AP; Hayes, P; Luong, T; Manousou, P; McCormick, PA; O'Beirne, J; Patch, D; Rodríguez-Perálvarez, M; Rolles, K; Samonakis, D; Thorburn, D; Tsochatzis, E, 2014) |
| "Pioglitazone was effective in decreasing serum HCV RNA at day-14 (n = 10; difference of means = 205,618 IU/ml; 95% CI 26,600 to 384,600; P<0." | 2.77 | Pioglitazone decreases hepatitis C viral load in overweight, treatment naïve, genotype 4 infected-patients: a pilot study. ( Buck, M; Chojkier, M; Donohue, M; Elkhayat, H; Sabry, D, 2012) |
| "We treated a patient with anterior ischemic optic neuropathy caused by peginterferon." | 2.45 | [Serious loss of vision in bilateral anterior ischemic optic neuropathy caused by interferon]. ( Kitagawa, C; Kiuchi, K; Miyashiro, M, 2009) |
| "Prednisolone were increased to 30 mg/day for his active entero-Behçet's disease, however, his burning retrosternal pain remained." | 2.42 | [A case of Behçet's disease with esophageal ulcers complicated with systemic sclerosis, chronic hepatitis C, and pancytopenia]. ( Adachi, D; Akiba, H; Akiyama, Y; Hirano, M; Mimura, T; Takeishi, M; Yokota, K, 2004) |
| "We experienced a patient with interstitial pneumonitis that was induced by simeprevir with PEG-IFN and RBV therapy for chronic hepatitis C in the early stages of therapy (8 wk after initiating therapy)." | 1.42 | Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis: first case report. ( Okubo, A; Tamaki, K, 2015) |
| "Sarcoidosis is an increasingly well-recognised complication of interferon therapy for hepatitis C infection, primarily manifesting with cutaneous or pulmonary involvement." | 1.37 | Sarcoid-related dacryoadenitis following treatment with interferon alpha and ribavarin for hepatitis C. ( Malhotra, R; Morley, AM; O'Sullivan, E; Thaung, C, 2011) |
| "Prednisolone was started with an initial dose of 20 mg/day." | 1.35 | Successful steroid treatment in a patient with membranoproliferative glomerulonephritis associated with hepatitis C virus. ( Hirakata, H; Hirano, T; Iida, M; Katafuchi, R; Masutani, K; Nakayama, M; Sakai, H; Sanai, T; Uesugi, N; Watanabe, I, 2009) |
| "Our report suggests that isolated autoimmune hemolytic anemia may be one of the unusual hematologic manifestations of chronic hepatitis C virus infection." | 1.31 | Chronic hepatitis C virus infection associated with primary warm-type autoimmune hemolytic anemia. ( Chang, FY; Chao, TC; Chen, CY; Chen, PM; Lee, SD; Yang, YH, 2001) |
| "Prednisolone treatment induced a complete remission of both clinical and hematological findings after two months, while Coombs' tests became negative after three months." | 1.30 | [Autoimmune hemolytic anemia in chronic hepatitis C virus infection treated with alpha-interferon: a therapy-related event or extra-hepatic immunologic manifestation?]. ( Antonaci, S; Giannoccaro, F; Pace, L; Schiraldi, O, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (11.11) | 18.2507 |
| 2000's | 15 (41.67) | 29.6817 |
| 2010's | 17 (47.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koshino, K | 1 |
| Ushigome, H | 1 |
| Masuda, K | 1 |
| Matsuyama, T | 1 |
| Harada, S | 1 |
| Nakamura, T | 1 |
| Nobori, S | 1 |
| Iida, T | 1 |
| Yoshimura, N | 1 |
| Nakamura, H | 1 |
| Fujieda, Y | 1 |
| Yasuda, S | 1 |
| Nakai, M | 1 |
| Atsumi, T | 1 |
| Manousou, P | 1 |
| Cholongitas, E | 1 |
| Samonakis, D | 1 |
| Tsochatzis, E | 1 |
| Corbani, A | 1 |
| Dhillon, AP | 1 |
| Davidson, J | 1 |
| Rodríguez-Perálvarez, M | 1 |
| Patch, D | 1 |
| O'Beirne, J | 1 |
| Thorburn, D | 1 |
| Luong, T | 1 |
| Rolles, K | 1 |
| Davidson, B | 1 |
| McCormick, PA | 1 |
| Hayes, P | 1 |
| Burroughs, AK | 1 |
| Jiang, W | 1 |
| Hidaka, H | 1 |
| Nakazawa, T | 1 |
| Kitagawa, H | 1 |
| Koizumi, W | 1 |
| Schummer, C | 1 |
| Schliemann, S | 1 |
| Fünfstück, V | 1 |
| Elsner, P | 1 |
| Tamaki, K | 1 |
| Okubo, A | 1 |
| de Ruiter, PE | 1 |
| Boor, PP | 1 |
| de Jonge, J | 1 |
| Metselaar, HJ | 1 |
| Tilanus, HW | 1 |
| Ijzermans, JN | 1 |
| Kwekkeboom, J | 1 |
| van der Laan, LJ | 1 |
| Kamada, T | 1 |
| Furuta, K | 1 |
| Tomioka, H | 1 |
| Leal, R | 1 |
| Pinto, H | 1 |
| Alves, R | 1 |
| Figueiredo, A | 1 |
| Weng, Q | 1 |
| Li, X | 1 |
| Ren, H | 1 |
| Xie, J | 1 |
| Pan, X | 1 |
| Xu, J | 1 |
| Chen, N | 1 |
| Kiuchi, K | 1 |
| Kitagawa, C | 1 |
| Miyashiro, M | 1 |
| Dietvorst, MH | 1 |
| van Wijngaarden, P | 1 |
| de Man, RA | 1 |
| Chung, H | 1 |
| Watanabe, T | 1 |
| Kudo, M | 1 |
| Maenishi, O | 1 |
| Wakatsuki, Y | 1 |
| Chiba, T | 1 |
| Ogdie, A | 1 |
| Schumacher, HR | 1 |
| Dai, L | 1 |
| Chen, LX | 1 |
| Einhorn, E | 1 |
| Pessler, F | 1 |
| Earnest, BS | 1 |
| Men, LC | 1 |
| Sukvinder Kaur, G | 1 |
| Alias, RB | 1 |
| Sunita Devi, H | 1 |
| Morley, AM | 1 |
| O'Sullivan, E | 1 |
| Thaung, C | 1 |
| Malhotra, R | 1 |
| Lim, JH | 1 |
| Lee, YN | 1 |
| Kim, YS | 1 |
| Kim, SG | 1 |
| Jeong, SW | 1 |
| Jang, JY | 1 |
| Kim, HS | 1 |
| Lee, SH | 1 |
| Park, TK | 1 |
| Chojkier, M | 1 |
| Elkhayat, H | 1 |
| Sabry, D | 1 |
| Donohue, M | 1 |
| Buck, M | 1 |
| Dragonas, C | 1 |
| Ehrenstein, B | 1 |
| Fleck, M | 1 |
| Kanda, T | 1 |
| Yokosuka, O | 1 |
| Imazeki, F | 1 |
| Yoshida, S | 1 |
| Suzuki, Y | 1 |
| Nagao, K | 1 |
| Saisho, H | 1 |
| Yokota, K | 1 |
| Hirano, M | 1 |
| Akiba, H | 1 |
| Adachi, D | 1 |
| Takeishi, M | 1 |
| Akiyama, Y | 1 |
| Mimura, T | 1 |
| Kakumu, S | 1 |
| Kato, T | 1 |
| Okai, T | 1 |
| Shiroma, T | 1 |
| Fukuda, J | 1 |
| Yokohari, R | 1 |
| Tadokoro, M | 1 |
| Maier, KP | 1 |
| Cai, FZ | 1 |
| Ahern, M | 1 |
| Smith, M | 1 |
| Sanai, T | 1 |
| Watanabe, I | 1 |
| Hirano, T | 1 |
| Nakayama, M | 1 |
| Sakai, H | 1 |
| Uesugi, N | 1 |
| Masutani, K | 1 |
| Katafuchi, R | 1 |
| Hirakata, H | 1 |
| Iida, M | 1 |
| Yoshikawa, M | 1 |
| Toyohara, M | 1 |
| Yamane, Y | 1 |
| Mimura, M | 1 |
| Miyamoto, Y | 1 |
| Ueda, S | 1 |
| Kawamoto, H | 1 |
| Fukui, H | 1 |
| Kobayashi, T | 1 |
| Hayashi, E | 1 |
| Nakamura, A | 1 |
| Nakamura, K | 1 |
| Makino, I | 1 |
| Giannoccaro, F | 1 |
| Pace, L | 1 |
| Antonaci, S | 1 |
| Schiraldi, O | 1 |
| Ignatova, TM | 1 |
| Aprosina, ZG | 1 |
| Belokrinitskaia, OA | 1 |
| Popova, IV | 1 |
| Siutkin, VE | 1 |
| Igaki, N | 1 |
| Nakaji, M | 1 |
| Moriguchi, R | 1 |
| Akiyama, H | 1 |
| Tamada, F | 1 |
| Goto, T | 1 |
| Guilera, M | 1 |
| Forns, X | 1 |
| Torras, X | 1 |
| Enríquez, J | 1 |
| Coll, S | 1 |
| Solà, R | 1 |
| Morillas, R | 1 |
| Planas, R | 1 |
| Ampurdanès, S | 1 |
| Soler, M | 1 |
| Costa, J | 1 |
| Sáiz, JC | 1 |
| Sánchez-Tapias, JM | 1 |
| Rodés, J | 1 |
| Krehmeier, H | 1 |
| Egberts, EH | 1 |
| Miwa, H | 1 |
| Furuya, T | 1 |
| Tanaka, S | 1 |
| Mizuno, Y | 1 |
| Chao, TC | 1 |
| Chen, CY | 1 |
| Yang, YH | 1 |
| Chen, PM | 1 |
| Chang, FY | 1 |
| Lee, SD | 1 |
| Bachmeyer, C | 1 |
| Mougeot-Martin, M | 1 |
| Cadranel, JF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Partially Blinded, Pilot Study of the Effects of Pioglitazone on HCV RNA in Overweight Subjects With Chronic HCV Genotypes 1 or 4 Infection.[NCT01157975] | Phase 2 | 0 participants (Actual) | Interventional | 2008-10-31 | Withdrawn (stopped due to Study was completed in another site) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for prednisolone and Chronic Hepatitis C
| Article | Year |
|---|---|
Membranous nephropathy associated with hepatitis C virus infection treated with corticosteroids and Ledipasvir-Sofosbuvir: a case report and review of literature.
Topics: Aged; Anti-Inflammatory Agents; Antiviral Agents; Benzimidazoles; Drug Therapy, Combination; Fluoren | 2017 |
[Serious loss of vision in bilateral anterior ischemic optic neuropathy caused by interferon].
Topics: Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; | 2009 |
[A case of Behçet's disease with esophageal ulcers complicated with systemic sclerosis, chronic hepatitis C, and pancytopenia].
Topics: Anti-Inflammatory Agents; Behcet Syndrome; Esophageal Diseases; Hepatitis C, Chronic; Humans; Male; | 2004 |
[Selection of therapy in patients with chronic hepatitis C showing features like autoimmune hepatitis].
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Hepatitis, Autoimmune; Hu | 2004 |
[Drug therapy in chronic liver disease].
Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Scleros | 2005 |
[Autoimmune hepatitis: progress in its treatment].
Topics: Azathioprine; Female; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Middle Aged; Prednisolone | 1999 |
3 trials available for prednisolone and Chronic Hepatitis C
| Article | Year |
|---|---|
Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes.
Topics: Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Hum | 2014 |
Pioglitazone decreases hepatitis C viral load in overweight, treatment naïve, genotype 4 infected-patients: a pilot study.
Topics: Adult; Antiviral Agents; Blood Glucose; Chemical and Drug Induced Liver Injury; Cytokines; Female; G | 2012 |
Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C.
Topics: Adult; Alanine Transaminase; Anti-Inflammatory Agents; Antiviral Agents; Double-Blind Method; Drug T | 2000 |
27 other studies available for prednisolone and Chronic Hepatitis C
| Article | Year |
|---|---|
Effective Treatment With Daclatasvir and Asunaprevir in Kidney Transplant Patients Infected With Hepatitis C Virus: A Report of Two Cases.
Topics: Aged; Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chr | 2017 |
Remission of Nephrotic Syndrome After Therapy for Chronic Hepatitis C Virus Infection in a Patient With Systemic Lupus Erythematosus.
Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis C, Chronic; Hu | 2018 |
Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)-CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Glucocorticoids; Hepatitis C, Chronic | 2014 |
[Cutaneous manifestation of late-type syphilis].
Topics: Administration, Oral; Biopsy; Ceftriaxone; Comorbidity; Diagnosis, Differential; Drug Therapy, Combi | 2014 |
Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis: first case report.
Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis C, Chronic; He | 2015 |
Prednisolone does not affect direct-acting antivirals against hepatitis C, but inhibits interferon-alpha production by plasmacytoid dendritic cells.
Topics: Antiviral Agents; Biomarkers; Carbamates; Cell Line, Tumor; Dendritic Cells; Drug Interactions; Drug | 2015 |
Drug-induced lung injury associated with combination therapy of daclatasvir and asunaprevir: The first case report.
Topics: Antiviral Agents; Carbamates; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Imidazoles; I | 2016 |
Late spontaneous decapsulation of the kidney graft in a patient with hepatitis C and treated with sirolimus: possible pathophysiological association in a rare complication.
Topics: Antiviral Agents; Cyclosporine; Drug Substitution; Graft Rejection; Hepatitis C, Chronic; Humans; Im | 2017 |
Autoimmune haemolytic anaemia due to chronic hepatitis C virus infection treated with prednisone, pegylated interferon and ribavirin.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Inter | 2009 |
Identification and characterization of IgG4-associated autoimmune hepatitis.
Topics: Adult; Aged; Cholangitis, Sclerosing; Female; Glucocorticoids; Hepatitis C, Chronic; Hepatitis, Auto | 2010 |
Synovial biopsy findings in arthritis associated with hepatitis C virus infection.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Biopsy; Drug Th | 2010 |
Chronic hepatitis C infection associated with neuromyelitis optica and antinuclear antibodies.
Topics: Anti-Inflammatory Agents; Antibodies, Antinuclear; Hepatitis C Antibodies; Hepatitis C, Chronic; Hum | 2010 |
Sarcoid-related dacryoadenitis following treatment with interferon alpha and ribavarin for hepatitis C.
Topics: Aged; Antiviral Agents; Biopsy; Dacryocystitis; Diagnosis, Differential; Female; Glucocorticoids; He | 2011 |
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Drug Therapy, Combination; Female; Fluorescein Angiograp | 2011 |
Tocilizumab treatment in a patient suffering from rheumatoid arthritis and concomitant chronic hepatitis C infection.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combin | 2012 |
Corticosteroids and lamivudine combined to treat acute severe flare-up in a chronic hepatitis B and C patient.
Topics: Acute Disease; Aged; Antiviral Agents; Betamethasone; Drug Therapy, Combination; Glucocorticoids; He | 2004 |
Marked increase of serum hepatitis C virus (HCV) RNA titer during treatment with high-dose prednisolone in a case of polymyositis.
Topics: Aged; Female; Glucocorticoids; Hepacivirus; Hepatitis C, Chronic; Humans; Polymyositis; Prednisolone | 2005 |
Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cryoglobulinemia; Drug Resistance, V | 2006 |
Successful steroid treatment in a patient with membranoproliferative glomerulonephritis associated with hepatitis C virus.
Topics: Aged; Female; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Hepatitis C, Chronic; Huma | 2009 |
Disappearance of serum HCV-RNA after short-term prednisolone therapy in a patient with chronic hepatitis C associated with autoimmune hepatitis-like serological manifestations.
Topics: Aged; Biopsy; Female; Hepacivirus; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Prednisolone | 1999 |
[Autoimmune hemolytic anemia in chronic hepatitis C virus infection treated with alpha-interferon: a therapy-related event or extra-hepatic immunologic manifestation?].
Topics: Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Female; Follow-Up Studies; Hepatitis C, Chr | 1999 |
[Myocarditis, polymyositis and Raynaud's syndrome in female patient with chronic hepatitis C].
Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis C, Chr | 1999 |
[A case of hepatitis C virus-associated glomerulonephropathy presenting with MPO-ANCA-positive rapidly progressive glomerulonephritis].
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Disease Progression; Female; | 2000 |
[Sarcoidosis after interferon-alpha treatment in hepatitis C].
Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Bronchoalveolar Lavage Fluid; Dyspnea; Follow-Up | 2001 |
Neurosarcoidosis associated with interferon therapy.
Topics: Administration, Oral; Anti-Inflammatory Agents; Antiviral Agents; Female; Hepatitis C, Chronic; Huma | 2001 |
Chronic hepatitis C virus infection associated with primary warm-type autoimmune hemolytic anemia.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Female; Hepatitis C, Chronic; Humans; | 2001 |
[Corticosteroids in the treatment of immune thrombocytopenic purpurain a patient with chronic hepatitis C virus infection].
Topics: Aged; Female; Glucocorticoids; Hepatitis C, Chronic; Humans; Prednisolone; Purpura, Thrombocytopenic | 2002 |